TRANSVAC-DS logo_200714.png
nick-fewings-zF_pTLx_Dkg-unsplash.jpg

Towards a sustainable European vaccine infrastructure

TIMELINE

01 June 2020 to 31 May 2022

FUNDING

1.88 M Euro

TRANSVAC-DS aims to consolidate the conceptual and technical design and ultimate implementation of a European vaccine R&D infrastructure.

TRANSVAC-DS Work package structure and flow:

Coordination

Work packages

WP

Input

Feasibly

and

option analysis

Gaps & needs analysis and context analysis of research infrastructure landscape 

Stakeholder engagement startegy

Socio-economic impact analysis 

Ethics

Communication and Dissemination

Recent News:

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 951668.

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 951668.

Apply for Vaccine R&D services and Training:

Connect

  • LinkedIn
  • Twitter
Subscribe to Our Newsletter

© 2020 European Vaccine Initiative. Designed by European Vaccine Initiative